Rethinking ME/CFS Diagnostic Reference Intervals via Machine Learning, and the Utility of Activin B for Defining Symptom Severity

Biomarker discovery applied to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a disabling disease of inconclusive aetiology, has identified several cytokines to potentially fulfil a role as a quantitative blood/serum marker for laboratory diagnosis, with activin B a recent addition. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Lidbury, Brett A., Kita, Badia, Richardson, Alice M., Lewis, Donald P., Privitera, Edwina, Hayward, Susan, de Kretser, David, Hedger, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787626/
https://www.ncbi.nlm.nih.gov/pubmed/31331036
http://dx.doi.org/10.3390/diagnostics9030079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787626/
https://www.ncbi.nlm.nih.gov/pubmed/31331036
http://dx.doi.org/10.3390/diagnostics9030079

Ejemplares similares